July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Toby Eyre Shared NEJM Article on Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia
Jun 17, 2025, 09:52

Toby Eyre Shared NEJM Article on Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia

Toby Eyre, CLL specialist at the Oxford University Hospitals, shared a post on X:

“Big CLL news!
Munir et al
OS and PFS adv for MRD driven I and V over ibrutinib in 1L CLL EHA 2025.
Congrats to all FLAIR trial group.
Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia, New England Journal of Medicine”

Title: Measurable Residual Disease-Guided Therapy for Chronic Lymphocytic Leukemia

Journal: NEJM

Authors: Talha Munir, Sean Girvan, David A. Cairns, Adrian Bloor, David Allsup, Abraham M. Varghese, Satyen Gohil, Shankara Paneesha, Andrew Pettitt, Toby Eyre, Christopher P. Fox, Francesco Forconi, Constantine Balotis, Nicholas Pemberton, Oonagh Sheehy, John Gribben, Nagah Elmusharaf, Simona Gatto, Gavin Preston, Anna Schuh, Renata Walewska, Lelia Duley, Nichola Webster, Surita Dalal, Andrew Rawstron, Dena Howard, Anna Hockaday, Sharon Jackson, Natasha Greatorex, Sue Bell, David Stones, Julia M. Brown, Piers E.M. Patten, Peter Hillmen

Read the full article.

Residual Disease-Guided Therapy

Read “25 Posts Not to Miss from EHA 2025“.

Residual Disease-Guided Therapy